Advisors Asset Management, Inc. Abb Vie Inc. Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

A detailed history of Advisors Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 179,142 shares of ABBV stock, worth $34.9 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

179,142

Previous 217,219 17.53%

Holding current value

$34.9 Million

Previous $39.6 Million 22.32%

% of portfolio

0.62%

Previous 0.78%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $5.89 Million - $6.88 Million	-38,077 Reduced 17.53%	179,142 $30.7 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $5.8 Million - $6.61 Million	-36,274 Reduced 14.31%	217,219 $39.6 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $4.53 Million - $5.11 Million	-32,946 Reduced 11.5%	253,493 $39.3 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $1.56 Million - $1.95 Million	-11,799 Reduced 3.96%	286,439 $38.6 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $659,566 - $759,588	4,561 Added 1.55%	298,238 $47.5 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $569,698 - $683,218	-4,119 Reduced 1.38%	293,677 $47.5 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $283,585 - $325,254	-2,113 Reduced 0.7%	297,796 $40 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $1.84 Million - $2.34 Million	-13,366 Reduced 4.27%	299,909 $45.9 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $1.11 Million - $1.37 Million	-8,384 Reduced 2.61%	313,275 $50.8 Million
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $1.19 Million - $1.51 Million	11,090 Added 3.57%	321,659 $43.6 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $2.42 Million - $2.75 Million	22,764 Added 7.91%	310,569 $33.5 Million
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $2.29 Million - $2.55 Million	21,794 Added 8.19%	287,805 $32.4 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $3.15 Million - $3.46 Million	30,762 Added 13.08%	266,011 $28.8 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.39 Million - $1.88 Million	17,268 Added 7.92%	235,249 $25.2 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $445,958 - $523,408	-5,191 Reduced 2.33%	217,981 $19.1 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $581,163 - $777,683	-7,921 Reduced 3.43%	223,172 $21.9 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $2.14 Million - $3.24 Million	-33,166 Reduced 12.55%	231,093 $17.6 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.46 Million - $3.08 Million	-34,076 Reduced 11.42%	264,259 $25.9 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $687,237 - $826,256	10,912 Added 3.8%	298,335 $22.6 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $1.11 Million - $1.42 Million	16,940 Added 6.26%	287,423 $20.9 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.31 Million - $1.54 Million	16,991 Added 6.7%	270,483 $21.8 Million
Q4 2018 Jan 31, 2019	BUY	$77.85 - $96.01 $38,769 - $47,812	498 Added 0.2%	253,492 $22.8 Million
Q3 2018 Nov 15, 2018	SELL	$88.91 - $98.84 $1.9 Million - $2.11 Million	-21,389 Reduced 7.8%	252,994 $23.9 Million
Q2 2018 Aug 22, 2018	BUY	$89.78 - $106.23 $23.3 Million - $27.5 Million	259,009 Added 1684.72%	274,383 $25.4 Million
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $38.5 Million - $45.6 Million	-429,111 Reduced 96.54%	15,374 $25.4 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $1.13 Million - $1.51 Million	-12,242 Reduced 2.68%	444,485 $51.3 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $6.47 Million - $7.1 Million	-72,265 Reduced 13.66%	456,727 $44.2 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $37 Million - $47.2 Million	528,992	528,992 $47 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Abb Vie Inc. Transaction History